Optimization of MSC therapeutic strategies for improved GVHD treatment
Mesenchymal stem cells (MSCs) have a powerful immunosuppressive capacity, and they have been used to treat numerous immune diseases, such as refractory graft-versus-host disease. Nevertheless, there are conflicting clinical data. To our knowledge, MSCs from different donors do not share the same qua...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2017-11-01
|
| Series: | Infection International |
| Subjects: | |
| Online Access: | http://www.degruyter.com/view/j/ii.2017.6.issue-1/ii-2017-0151/ii-2017-0151.xml?format=INT |